Chemoinformaics analysis of Methyl acetoacetate
| Molecular Weight | 116.116 | nRot | 2 |
| Heavy Atom Molecular Weight | 108.052 | nRig | 2 |
| Exact Molecular Weight | 116.047 | nRing | 0 |
| Solubility: LogS | -0.006 | nHRing | 0 |
| Solubility: LogP | -0.237 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 16.0903 |
| nHD | 0 | BPOL | 11.4977 |
| QED | 0.38 |
| Synth | 2.023 |
| Natural Product Likeliness | 0.573 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.02 |
| HIA | 0.008 |
| CACO-2 | -4.496 |
| MDCK | 0.0000494 |
| BBB | 0.966 |
| PPB | 0.171452 |
| VDSS | 0.41 |
| FU | 0.835114 |
| CYP1A2-inh | 0.04 |
| CYP1A2-sub | 0.511 |
| CYP2c19-inh | 0.049 |
| CYP2c19-sub | 0.7 |
| CYP2c9-inh | 0.009 |
| CYP2c9-sub | 0.253 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.359 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.293 |
| CL | 7.772 |
| T12 | 0.908 |
| hERG | 0.044 |
| Ames | 0.021 |
| ROA | 0.193 |
| SkinSen | 0.894 |
| Carcinogencity | 0.07 |
| EI | 0.993 |
| Respiratory | 0.758 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.965905 |